Sarah Hein
FounderCEO, Co-Founder at March Biosciences
Houston, Texas, United States
FoundedMarch Biosciences
Find your path to Sarah
120 people in our graph share verified history with Sarah β schools, employers, funds. One of them is your warm intro.
About
Sarah Hein is the cofounder and CEO of March Biosciences, a clinical-stage cell-therapy company focused on hematological malignancies. She previously served as the founding Entrepreneur in Residence for the Texas Medical Center Innovation Accelerator for Cancer Therapeutics, cofounder and Vice President of Operations at Courier Therapeutics (acquired by Valo Health), and Director of Research at Resonant Therapeutics. She began her career as a Venture Fellow at Mercury Fund after earning a PhD in Molecular Biology from Baylor College of Medicine.
CEO, Co-Founder at March Biosciences
Intro paths
In turn, Sarah can intro founders to March Biosciences's investors below.
March Biosciences's investors Β· 8
Co-founders at March Biosciences

Experience
- March BiosciencesCofounder & CEOcurrent2022 β presentHouston, Texas, United States
- TMC InnovationEntrepreneur in Residence2020 β 2022Houston, Texas
- Courier TherapeuticsVice President of Operations2019 β 2020
- Courier TherapeuticsDirector of Development2016 β 2019Houston, TX
- Resonant TherapeuticsDirector of Research2016 β 2019Houston, Texas
- Mercury FundVenture Fellow2016 β 2017Houston, Texas
- Rice UniversityGraduate Teaching Assistant2016
- Baylor College of MedicineGraduate Student Research Assistant2010 β 2016Houston, TX
- University of WyomingGraduate Student Research Assistant2009 β 2010Laramie, WY
- University of WyomingGraduate Mentor in Summer Research Apprentice Program (SRAP)2009Laramie, WY
- University of WyomingUndergraduate Teaching Assistant2009Laramie, WY
- University of WyomingUndergraduate Research Assistant2006 β 2009Laramie, WY
- University of WyomingUndergraduate Teaching Assistant2007Laramie, WY
Skills & more
+12 more
BudgetingEntrepreneurshipMolecular BiologyMicrobiologyBiochemistryCell BiologyLaboratoryCell CulturePythonAdobe IllustratorMicrosoft OfficeMicrosoft PowerPointFrom Sarah's professional profile.
Frequently asked questions
- Who is Sarah Hein?
- Sarah Hein is the cofounder and CEO of March Biosciences, a clinical-stage cell-therapy company focused on hematological malignancies. She previously served as the founding Entrepreneur in Residence for the Texas Medical Center Innovation Accelerator for Cancer Therapeutics, cofounder and Vice President of Operations at Courier Therapeutics (acquired by Valo Health), and Director of Research at Resonant Therapeutics. She began her career as a Venture Fellow at Mercury Fund after earning a PhD in Molecular Biology from Baylor College of Medicine.
- Where does Sarah Hein work?
- Sarah Hein is CEO, Co-Founder of March Biosciences.
- What companies did Sarah Hein found?
- Sarah Hein founded March Biosciences.
- Where did Sarah Hein go to school?
- Sarah Hein studied at Baylor College of Medicine (PhD, Molecular and Cellular Biology); University of Wyoming (MS, Reproductive Biology); University of Wyoming (BS, Molecular Biology with Honors).
Founder mafias
Baylor College of Medicine mafia15
Also came through, then founded or led a company.
+ 8 more
Mercury Fund mafia11
Also came through, then founded or led a company.
+ 4 more
University of Wyoming mafia11
Also came through, then founded or led a company.
+ 4 more
Same school
Also attended Baylor College of Medicine40
+ 34 more
Also attended University of Wyoming24
+ 18 more
Shared employers
Also worked at Mercury Fund33
+ 27 more
Also worked at Rice University65
+ 59 more
Also worked at Baylor College of Medicine58
+ 52 more




















































